you are here:

Natural Capsules Ltd.

BSE Live

Nov 27, 16:00
81.50 -0.85 (-1.03%)
Volume
AVERAGE VOLUME
5-Day
3,530
10-Day
3,608
30-Day
6,919
7,508
  • Prev. Close

    82.35

  • Open Price

    83.95

  • Bid Price (Qty.)

    80.75 (2)

  • Offer Price (Qty.)

    82.15 (250)

NSE Live

Dec 27, 11:22
NT* 0.00 (0.00%)
Volume
No Data Available
0
  • Prev. Close

    -

  • Open Price

    -

  • Bid Price (Qty.)

    - (0)

  • Offer Price (Qty.)

    - (0)

Natural Capsules is not listed on NSE

ANNOUNCEMENTS ON Natural Capsule

  • Nov 24, 2020 14:48 Source: BSE

    Natural Capsules - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

    Subject: Intimation under Regulation 39(3) of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 Pursuant to Regulation 39(3) of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, we wish to bring to inform that one of the shareholder has reported to the Company about the loss of his share certificates and requested the Company to issue duplicate share certificates.The particulars relating to loss of share certificates are attached.

  • Nov 16, 2020 16:53 Source: BSE

    Natural Capsules - Disclosure Under Regulation 29(2) Of SEBI (SAST) Regulations, 2011

    This is to inform you that pursuant to Regulation 29(2) of SEBI (SAST) Regulations, 2011, we have received the attached disclosures from the promoters Mr. Sushil Kumar Mundra, Mrs. Indra Mundra & Mrs. Sharda Mundra. Kindly take the same on your records.

  • Nov 16, 2020 14:46 Source: BSE

    Natural Capsules - Revised Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201

    The Exchange has received the revised disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sharda Mundra

  • Nov 16, 2020 14:42 Source: BSE

    Natural Capsules - Revised Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

    The Exchange has received the revised disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Sushil Kumar Mundra

  • Nov 16, 2020 11:34 Source: BSE

    Natural Capsules - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

    The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Indra Mundra

  • Nov 14, 2020 16:38 Source: BSE

    Natural Capsules - Disclosure In Terms Of Regulation 7(2) Of SEBI (Prohibition Of Insider Trading) Regulations, 2015

    Enclosed please find disclosure in Form C from Mr. Sushil Kumar Mundra (Promoter & Director), Mrs. Indra Mundra (Promoter) & Mrs. Shardha Mundra (Promoter) in terms of above Regulations for your information and records. The above is being sent within 2 trading days of the receipt of the disclosure. Kindly take the same on your information and records.

  • Nov 12, 2020 17:54 Source: BSE

    Natural Capsules - Announcement under Regulation 30 (LODR)-Newspaper Publication

    Subject: Newspaper Publication With reference to the captioned subject, We hereby inform that, 1. Notice of 136th Meeting of Board of Directors has been published in Business Line-An English daily & Sanjevani- a Kannada daily; 2. Financial Results for the Second quarter & half year ended 30th September, 2020 has been published in Business Line-An English daily & Sanjevani- a Kannada daily. We enclose herewith the copies of Newspaper cuttings for your reference and records.

  • Nov 10, 2020 18:37 Source: BSE

    Natural Capsules - Disclosure Of Related Party Transactions For The Half Year Ended 30.09.2020

    In Compliance with Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find the enclosed disclosure of Related Party Transactions in the format specified in the relevant accounting standards for the half year ended 30.09.2020. Kindly take the above information on your record.

  • Nov 07, 2020 20:01 Source: BSE

    Natural Capsules - Announcement under Regulation 30 (LODR)-Meeting Updates

    Sub: Addendum to Outcome Board Meeting: With reference to our letter dated 07.11.2020, regarding outcome of Board Meeting, we wish to inform that by oversight data mentioned in half ended columns of UNAUDITED CONSOLIDATED FINANCIAL RESULT FOR THE SIX MONTH ENDED SEPTEMBER, 2020 were incorrect, and now corrected statement is being filed. Kindly take the above information on records.

  • Nov 07, 2020 18:16 Source: BSE

    Natural Capsules - Outcome Of Board Meeting

    Board of Directors at their meeting held on 07.11.2020, inter alia has transacted the following: Adoption of Unaudited Standalone & Unaudited Consolidated Financial Results for the quarter & half year Ended 30th September, 2020. Further, in compliance with Regulation 33 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, we submit herewith, the unaudited standalone and consolidated financial results along Limited Review report for the Second quarter & half-year ended 30th September, 2020. The meeting commenced at 04.00 PM and concluded at 6.00 PM. Kindly take the above information on records.

CORPORATE ANNOUNCEMENTS

BOARD MEETING

Meeting Date : Nov 07, 2020
Remark : Quarterly Results